P349-0185 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-3-({imidazo[1,2-a]pyrazin-3-yl}amino)propanamide

P349-0185 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-3-({imidazo[1,2-a]pyrazin-3-yl}amino)propanamide
P349-0185 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-3-({imidazo[1,2-a]pyrazin-3-yl}amino)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P349-0185
N-[(2H-1,3-benzodioxol-5-yl)methyl]-3-({imidazo[1,2-a]pyrazin-3-yl}amino)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P349-0185

Molecular Formula

C17H17N5O3 (C17 H17 N5 O3)

Compound Name

N-[(2H-1,3-benzodioxol-5-yl)methyl]-3-({imidazo[1,2-a]pyrazin-3-yl}amino)propanamide

IUPAC name

N-[(2H-13-benzodioxol-5-yl)methyl]-3-({imidazo[12-a]pyrazin-3-yl}amino)propanamide

SMILES

O=C(CCNc1cnc2n1ccnc2)NCc(cc1)cc2c1OCO2

InChI

InChI=1S/C17H17N5O3/c23-17(21-8-12-1-2-13-14(7-12)25-11-24-13)3-4-19-16-10-20-15-9-18-5-6-22(15)16/h1-2,5-7,9-10,19H,3-4,8,11H2,(H,21,23)

InChI Key

AMBYBCWQANVACR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27573292

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

339.35

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.842

Distribution Coefficient, logD

0.842

Water Solubility, LogSw

-1.47

Polar Surface Area

70.892

Acid Dissociation Constant (pKa)

14.31

Base Dissociation Constant (pKb)

3.88

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.50

P349-0185 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with P349-0185 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P349-0185?
Check Price and Availability of P349-0185, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P349-0185 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P349-0185
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P349-0185
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P349-0185 available by request